Shots: South Korea’s FTC has approved Danaher’s $21.4 billion acquisition of GE biopharma on condition that the companies will sell eight bioprocessing product assets addressing monopoly concerns The FTC’s approval […]readmore
Tags : $21.4B
Shots: Danaher to acquire biopharma unit of GE Life Sciences (GE Biopharma), in all stock transaction making total deal value of $21.4 B. GE Biopharma to receive $21.4B, including $18B […]readmore